Finance

Dollar Recovers, Oil Doesn’t

The US dollar’s recovery that began yesterday continues today.  The euro reached the 50% retracement objective of its slide since mid-October (~$1.2565) and now is more than a full cent lower. The dollar’s slump against the yen ended just above the JPY115.50 level, also a key technical retracement level.  The dollar’s high today was JPY117.50.   This is…

Back Monetary Reflections… More To Come In 2015

I reflected in a post last week that we should have had less accommodative monetary policy and more fiscal policy since the crisis… Thoughts on Investment, IS-LM & Effective Demand. Today Paul Krugman also had what appears to be a moment of reflection upon monetary perspectives… The Limits of Purely Monetary Policies. He recognizes the limitations of…

FXCM, Alpari Suspend Ruble Trading

The crisis revolving around the Russian ruble and the rout in oil prices is sending shockwaves throughout the financial marketplace. Investors are looking for a way to cover their bonds as yields on British, German and Japan sovereign debt hit record lows and long-dated U.S. and Australian yields reached their lowest since 2012. Russia’s faltering…

S&P 500: Short-term Outlook 16 December 2014

by Erik McCurdy, Prometheus Market Insight Technical Analysis The index closed moderately lower yesterday (Tuesday 16 December 2014), retreating further from recent highs of the cyclical bull market from 2009 and moving below congestion support in the 1,980 area. Technical indicators are extremely bearish overall, strongly favoring a continuation of the decline from last week.  …

Market Selling Intensifies

It ended up a roller coaster ride with markets rallying, then suffering losses to return indices to their lows. Volume rose in confirmed distribution, and many indices now sit inside Fib retracement levels – a good place to launch a relief bounce. The S&P finished just a few points above the 50% Fib level, with…

TPI Expects To Receive GMP By End Of 2014; NVIV Reports FDA Appro

Tianyin Pharmaceutical Co., Inc. (NYSE MKT: TPI), a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded generics and active pharmaceutical ingredients (API) updates it expects to receive the formal Good Manufacturing Practice (GMP) certificate for its Qionglai Facility’s (QLF) from the China Food & Drug Administration’s (CFDA) by the end…